Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Mngqibisa R, Kassim S, McDonald C, Bloch M, et al. Safety and Efficacy of Doravirine/Islatravir (100 mg/0.25 mg) Once Daily after Islatravir Dose Reduction from 0.75 mg: Week 96 Results from an Open-Label Phase 3 Study in Adults with HIV-1. J Acquir Immune Defic Syndr 2026 Oct 12. doi: 10.1097/QAI.0000000000003981.
PMID: 42861969


Privacy Policy